Cover for 2023 July Quarterly Pipeline a view into upcoming specialty & traditional drugs Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pipeline_jul?fr=sMjFiMTc3NDc1ODQ About...

Cover for 2023 October Quarterly Pipeline A view into upcoming specialty & traditional drugs Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pipeline_oct?fr=sMTIyZTc3NDc1ODQ About...

Academy of Managed Care Pharmacy (AMCP)

BioPharma Dive: There are no drugs specifically for polycystic ovary syndrome, a chronic condition that can cause infertility. One study is testing whether Wegovy might be beneficial.

publications Quarterly Drug Pipeline: January 2025 Clinical insights and competitive intelligence on anticipated drugs in development January 30, 2025 Editor-in-chief's message Welcome to the Prime...

Quarterly Drug Pipeline: January 2024 Clinical insights and competitive intelligence on anticipated drugs in development Drug Pipeline Clinical insights and competitive intelligence on anticipated...

PUBLICATIONS FDA Decisions Expected Drug pipeline for December 2024 November 15, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have...

Publications Clinical Highlights: April 2025 Your monthly source for drug information highlights. April 29, 2025 Trending topics Results from the double-blind, placebo-controlled SOUL trial...

Lassen, chief clinical officer at Prime Therapeutics/Magellan Rx, shares insights on GLP-1 weight-loss drugs and evidence-based approaches to providing the kind of care we’d want for our loved ones.

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

Star Tribune

Shortages in the manufacturing chain have led to label hopping and an increase in off-label use

In the latest episode of the “Pharmacy Friends” podcast, hear about a new clinical report from Prime Therapeutics that dives into the latest evidence-based insights related to the rising prevalence...

Learn with Biosimilar Basics. Part 1 starts with an overview of biosimilar products, sharing what biosimilar drugs are and the difference vs generic drugs.

The American Journal of Managed Care (AJMC): The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still...

CNN: At 37:03, listen to fitness expert Jillian Michaels cite Prime/Magellan Rx research on a podcast recording of a June 21 CNN broadcast

Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime...

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

PUBLICATIONS FDA Decisions Expected: August 2025 Your monthly synopsis of new drugs expected to hit the market July 16, 2025 Drug pipeline for August 2025 At Prime Therapeutics (Prime), we have...

Support your members with diabetes and obesity We help members navigate the challenges of diabetes and obesity with our holistic, customized approach to care. Breadcrumb Home Our solutions...

Academy of Managed Care Pharmacy (AMCP)'s Annual Meeting gathers thousands of health plan, pharmacy benefit management and biopharmaceutical experts to help define the future of managed care pharmacy.

Experience pharmacy solutions built for you Get holistic, people-centered solutions that help you save money while delivering a better member experience. Breadcrumb Home Who we are About us...

From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights

Prime’s industry-leading research on GLP-1s was recognized at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston

Forbes

Read Drug Approvals Monthly Update: March 2024 Critical updates in an ever-changing environment Drug Approval Update Specialty New drugs 3/13/2024 Tevimbra™ (tislelizumab-jsgr) Tevimbra, a...

U.S. News & World Report

Specialty Pharmacy Continuum

Forbes

Publications Clinical Highlights: November 2024 Your monthly source for drug information highlights. November 27, 2024 Weight Management Corner: catch up on recent publications and study findings...

Prime Therapeutics Report shares more about single-treatment gene therapies and proper management

Gene therapy harnesses the body’s capacity to heal itself

Cover image for The evolution of GLP-1s Developing a holistic, individualized strategy to capitalize on opportunities and outcomes Prime Therapeutics /the-evolution-of-glp-1s About Prime...

publications Metabolic dysfunction–associated steatohepatitis (MASH) A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum August 15, 2025 Prime Therapeutics’...

New report explores traditional, specialty therapy trend impact to employers

From next-gen CFTR modulators to gene therapy and real-world drug impact, cystic fibrosis care is constantly evolving. Maryam Tabatabai, PharmD, of Prime Therapeutics, explains how innovative...

Publications Clinical Highlights: February 2025 Your monthly source for drug information highlights. February 28, 2025 Trending topics The annual report Cancer statistics, 2025 from the American...

cover image for Summer 2025 Issue: Clinical Insights – MASH A new era in liver health: Treatment innovation, payer strategy, and pipeline momentum Prime Therapeutics...

Learn with Biosimilar Basics. Part 2 covers biosimilar naming conventions and other nomenclature including common drug pipeline content acronyms.

Breadcrumb Home Newsroom Custom Content Publications Clinical Highlights: September 2024 PUBLICATIONS Clinical Highlights: September 2024 Your monthly source for drug information highlights....

Critical updates in an ever-changing environment.

Critical updates in an ever-changing environment

A roundup of Prime's award-winning presentations and insights at AMCP Annual Meeting in Houston

Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model

Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs

This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news of note on drugs in the approval process.

Read Clinical News: May 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA ALERT ON PREGNANCY RISKS WITH...

Read Clinical News: April 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics NEW PRESCRIPTION DIGITAL THERAPEUTIC...

Breadcrumb Prime Therapeutics Newsroom Custom Content Publications Clinical Highlights: October 2024 Publications Clinical Highlights: October 2024 Your monthly source for drug information...

Publications Clinical Highlights: December 2024 Your monthly source for drug information highlights. December 30, 2024 Weight Management Corner An analysis published in The Lancet details national-...

publications High-Cost Therapy Profile: July 2025 Rebisufligene etisparvovec Intravenous (IV) Metabolic gene therapy July 3, 2025 Proposed indications Sanfilippo A syndrome (Mucopolysaccharidosis...

publications Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights July 1, 2025 Trending Topics Hot topics On June 9, 2025, the United States (U.S.)...

Perspectives High-Cost Therapy Profile: January Detailed information about Atidarsagene Autotemcel Intravenous (IV) High Cost Therapy Profile Atidarsagene Autotemcel Intravenous (IV) Orchard ...

publications ASCO 2025 Spotlight: The Trials Making Headlines July 14, 2025 Author: Abby Kim, PharmD, BCOP The 2025 American Society of Clinical Oncology (ASCO) annual meeting lived up to its...

Publications Clinical Highlights: January 2025 Your monthly source for drug information highlights. January 30, 2025 Weight management corner The Lancet Diabetes & Endocrinology Commission has...

publications Summer 2025 Issue: Spotlight on HIV and Specialty Drug Trends New therapies, payer strategies and pipeline updates shaping the future of managed care July 15, 2025 The Prime...

publications High-Cost Therapy Profile: August 2025 Apitegromab Intravenous (IV) | Scholar Rock, LLC Neuromuscular August 15, 2025 Proposed indications Spinal muscular atrophy (SMA) FDA...

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans